Release Date: 19/05/10 08:28 Summary: First Quarter Report - 31 March 2010 Price Sensitive: Yes Download Document 568.72KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%